LRRK2
细胞生物学
脑损伤
信号转导
神经科学
生物
化学
基因
生物化学
突变
作者
Yun-Hee Bae,Hyejin Joo,Jinhyun Bae,Seung Jae Hyeon,Song Her,Eunhwa Ko,Hwan Geun Choi,Hoon Ryu,Eun‐Mi Hur,Youngmin Bu,Byoung Dae Lee
标识
DOI:10.1038/s41419-018-1180-y
摘要
Abstract Leucine-rich repeat kinase 2 ( LRRK2 ), originally identified as a causative genetic factor in Parkinson’s disease, is now associated with a number of pathologies. Here, we show that brain injury induces a robust expression of endogenous LRRK2 and suggest a role of LRRK2 after injury. We found that various in vitro and in vivo models of traumatic brain injury (TBI) markedly enhanced LRRK2 expression in neurons and also increased the level of hypoxia-inducible factor (HIF)-1α. Luciferase reporter assay and chromatin immunoprecipitation revealed direct binding of HIF-1α in LRRK2 proximal promoter. We also found that HIF-1α-dependent transcriptional induction of LRRK2 exacerbated neuronal cell death following injury. Furthermore, application of G1023, a specific, brain-permeable inhibitor of LRRK2, substantially prevented brain tissue damage, cell death, and inflammatory response and alleviated motor and cognitive defects induced by controlled cortical impact injury. Together, these results suggest HIF-1α-LRRK2 axis as a potential therapeutic target for brain injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI